Events

Covering Clinical Development, Bioprocessing & Manufacturing, Cancer Immunotherapy and much more. The Start-to-Finish of Vaccines from research, immune profiling & clinical trials to manufacture and access.

BioTrinity is OBN's flagship two-day conference for the life sciences industry, designed to catalyse growth for all who attend. The delegate mix comprises early stage and emerging life sciences R&D companies, investors, big pharma, academics, charities, government, and broad range of valued service providers.

The ABPI exists to make the UK the best place in the world to research, develop and access medicines and vaccines to improve patient care. We represent companies of all sizes which invest in making and discovering medicines and vaccines to enhance and save the lives of millions of people around the world.

Following a successful AXS26 Summit, Asembia is excited to be planning next year’s conference comprising networking sessions, exhibits and more. Each year, Asembia’s Specialty Pharmacy Summit is at the epicenter of the pharmacy industry, providing a unique opportunity for stakeholders throughout the industry to understand challenges, generate solutions and define the future.

Europe's premier conference in the cell and gene therapy industry today.

ISCT is the global leader focused on pre-clinical and translational aspects of developing cell and gene-based therapeutics, thereby advancing scientific research into innovative treatments for patients. Through strong relationships with global regulatory agencies, academic institutions, and industry partners, ISCT drives the advancement of research into a standard of care.

Biosimilar medicines stand at the crossroads of access, sustainability, and industrial resilience. This year’s Biosimilar Medicines Conference programme will explore how strategic coalitions for change can emerge across value chains, geographies, and stakeholders to unlock the full potential of biosimilar medicines to deliver meaningful impact for patients, health systems and society at large.

ACCESS Forum brings together Thought Leaders, Executives, and Key Stakeholders across Market and Patient Access several times a year to engage, get smarter, problem-solve and challenge the system.

Stay informed and connected by attending the US Pharma and Biotech Summit 2025. Organized by FT Live in collaboration with Endpoints News, the event will bring together top executives, investors and experts to share powerful insights into the future of life sciences in America and worldwide.

Policy makers and payers face mounting pressure to make evidence-based decisions that balance innovation with sustainable access. The healthcare ecosystem, real-world data, health economic models, and clinical outcomes assessments continuously demonstrate their ability to generate high-quality evidence and guide these decisions. Health economics and outcomes research (HEOR) stands at the forefront, providing rigorous data, frameworks, and insights needed to demonstrate value, guide resource allocation, and shape policies that matter.

Join us in May 2026 for the third annual exclusive gathering of senior level investors, corporate executives, entrepreneurs and start-up leaders from biotech, tech bio, biomedical research, drug discovery and healthcare sectors.

By bringing together people with rare diseased and patient advocates, policy makers, healthcare industry representatives, clinicians, regulators and Member State representatives EURORDIS harnesses the power of this extensive network to shape goal-driven rare disease policies of the future.